Effect of an inhibitor of DPP-IV on glucagon secretion in diabetes type 1 with or without autonomic vegetative neuropathy [Effet d'un inhibiteur de la DPP-IV sur la secretion de glucagon au cours du diabete de type 1 avec ou sans neuropathie autonome vegetative]

Trial Profile

Effect of an inhibitor of DPP-IV on glucagon secretion in diabetes type 1 with or without autonomic vegetative neuropathy [Effet d'un inhibiteur de la DPP-IV sur la secretion de glucagon au cours du diabete de type 1 avec ou sans neuropathie autonome vegetative]

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Mar 2014

At a glance

  • Drugs Vildagliptin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms DPPNAC
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Jan 2013 Planned end date changed from 29 Feb 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Planned End Date changed to 29 Feb 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top